Source comparison
Melanotan-2 40s Protocol Comparison
Starting Dose 250–500mcg 100–150mcg Reduced MC1R density requires gradual receptor engagement; lower initial dose minimizes cardiovascular spike Titration Duration 10–14 days 4–6 weeks Extended titration allows MC3/MC4 desensitization before reaching therapeut
This comparison does not assign a generated winner or score.
- Starting Dose
- 250–500mcg
- 100–150mcg
- Reduced MC1R density requires gradual receptor engagement; lower initial dose minimizes cardiovascular spike
- Titration Duration
- 10–14 days
- 4–6 weeks
- Extended titration allows MC3/MC4 desensitization before reaching therapeutic melanogenic dose
- Maintenance Frequency
- Daily (1000–1500mcg/week total)
- Twice weekly (1000–1500mcg/week total)
- Slower peptide clearance after 40 makes daily dosing cumulative; twice-weekly prevents receptor oversaturation
- Blood Pressure Monitoring
- Optional
- Mandatory (daily during titration)
- MC4 receptor activation increases sympathetic tone; users over 40 have higher baseline cardiovascular risk
- Maximum Single Dose
- 1000mcg+
- 750mcg
- Higher doses provide minimal additional melanogenesis after 40 but compound cardiovascular and GI side effects
- Professional Assessment
- Modified protocol addresses age-related receptor changes and metabolic slowdown. Standard dosing after 40 prioritizes speed over safety